Is fetal RHD typing in all RhD negative women cost effective?

BMJ

Volumn 336, Issue 7650, 2008, Pages 906-

  Szczepura, Ala ^a   Osipenko, Leeza ^a   Bonsel, Gouke ^b   Krauth, Christian ^c   Haverkamp, Alexander ^d  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY; RHESUS D ANTIGEN;

ALLOIMMUNIZATION; ANTIGEN DETECTION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FETUS OUTCOME; GENOTYPE; HUMAN; LETTER; MEDICAL DECISION MAKING; NON INVASIVE PROCEDURE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

COST-BENEFIT ANALYSIS; FEMALE; FETAL DISEASES; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; RH ISOIMMUNIZATION; RHO(D) IMMUNE GLOBULIN;

EID: 43049133277     PISSN: 09598138     EISSN: 14685833     Source Type: Journal    
DOI: 10.1136/bmj.39556.499549.80     Document Type: Letter

References (5)

1. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008; 336: 816-8. (12 April.)
2. National Institute for Health and Clinical Excellence. Technology appraisal 41. Routine anti-D prophylaxis for pregnant women who are RhD negative. 2002. www.nice.org.uk/page.aspx?o=31679.
3. Chilcott J, Tappenden P, Jones ML, Wight J, Forman K, Wray J, et al. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative. BJOG 2004; 111: 903-7.
4. Chitty LS, van der Schoot CE, Hahn S, Neil D. Avent SAFE—The Special Non-invasive Advances in Fetal and Neonatal Evaluation Network: aims and achievements. Prenatal Diagn 2008; 28: 83-88.
5. Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood—a meta-analysis. Am J Obstet Gynecol 2006; 195: 1163-73.